EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeit

In‐Office Steroid Injections for Idiopathic Subglottic Stenosis: A Systematic Review

Eric Delgado Rendon iD, Nawfal Saleem, Natalie Weiss iD, Amy Rutt iD

The Laryngoscope · 2026-05 · 136 (5) · 2018-2025

DOI: 10.1002/lary.70300 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Laryngoscope, online erschienen am 06.12.2025. Verfasst von Eric Delgado Rendon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Florida State University College of Medicine, Tallahassee, Florida, USA. Hauptthemen laut MEDLINE: Laryngostenosis, Glucocorticoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To critically evaluate clinical and voice‐related outcomes of in‐office serial intralesional steroid injection (SILSI) in adults diagnosed with idiopathic subglottic stenosis (iSGS). Data Sources MEDLINE, Embase, CINAHL Ultimate, CENTRAL, ClinicalTrials.gov . Review Methods A systematic search of databases was conducted from inception through April 5, 2025. Studies eligible for inclusion must have reported on adult SILSI recipients undergoing management of iSGS. Articles were independently screened and reviewed by two authors for treatment variables including steroid protocol, clinical outcomes, respiratory function, vocal outcomes, and complications.

Results

Of 383 studies identified, 14 met inclusion criteria ( n = 371). Triamcinolone was the most commonly used agent in 10 studies. Steroid dosage, number of treatment sessions, and injection interval varied widely across studies. Improvements in surgery‐free interval, peak expiratory flow, dyspnea index, degree of stenosis, and voice‐related outcomes were observed in several studies. No major complications were reported in the included studies.

Conclusion

Current evidence suggests SILSI represents a promising adjunctive therapy in the treatment of iSGS, with improvement noted across several measures. However, significant variability in steroid treatment regimens and inconsistent reporting of outcomes complicate interpretations of efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LaryngostenosisGlucocorticoidsHumansInjections, IntralesionalTreatment OutcomeTriamcinoloneAdult

Stichwörter der Autor:innen

SILSIidiopathic subglottic stenosisin‐office steroid injection

Substanzen

GlucocorticoidsTriamcinolone

Autor:innen und Institutionen

  • Florida State University College of Medicine, Tallahassee, Florida, USA.
  • Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA.
  • Department of Otolaryngology - Head & Neck Surgery, Mayo Clinic, Jacksonville, Florida, USA.

ORCID-Profile: Eric Delgado Rendon, Natalie Weiss, Amy Rutt

Zitieren

APA

Delgado Rendon, E., Saleem, N., Weiss, N., & Rutt, A. (2026). In‐Office Steroid Injections for Idiopathic Subglottic Stenosis: A Systematic Review. The Laryngoscope, 136(5), 2018-2025. https://doi.org/10.1002/lary.70300

Vancouver

Delgado Rendon E, Saleem N, Weiss N, Rutt A. In‐Office Steroid Injections for Idiopathic Subglottic Stenosis: A Systematic Review. The Laryngoscope. 2026;136(5):2018-2025. doi:10.1002/lary.70300

BibTeX
@article{DelgadoRendon2026,
  author = {Delgado Rendon, Eric and Saleem, Nawfal and Weiss, Natalie and Rutt, Amy},
  title = {In‐Office Steroid Injections for Idiopathic Subglottic Stenosis: A Systematic Review},
  journal = {The Laryngoscope},
  year = {2026},
  volume = {136},
  number = {5},
  pages = {2018--2025},
  doi = {10.1002/lary.70300}
}
Kostenlos starten →